Imidex, an AI-enabled medical device company specializing in lung cancer detection, and DNA-sequencing technology specialist Orbit Genomics announced a strategic partnership to combine their offerings to help reduce lung cancer fatalities.
Imidex's FDA 510(k)-cleared VisiRad XR device allows for detecting lung nodules as small as 6mm in chest X-rays. The company touts the VisiRad XR as having an...
